1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
(
- Contribution to journal › Article
- 2020
-
Mark
Levodopa infusion in Parkinson's disease : Individual quality of life
(
- Contribution to journal › Article
- 2015
-
Mark
Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease
(
- Contribution to journal › Article
- 2014
-
Mark
A porous silicon immunoassay platform for fluorometric determination of alpha-synuclein in human cerebrospinal fluid
(
- Contribution to journal › Article
- 2013
-
Mark
Differences Between Parkinson's and Huntington's Diseases and Their Role for Prioritization of Stem Cell-Based Treatments
(
- Contribution to journal › Article
- 2011
-
Mark
Quality of Life and the Effect of Memantine in Dementia with Lewy Bodies and Parkinson's Disease Dementia.
(
- Contribution to journal › Article
-
Mark
Systemic administration of Neuregulin-1ß(1) protects dopaminergic neurons in a mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Knock down of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Drug-related problems in Parkinson's disease: the role of community pharmacists in primary care
(
- Contribution to journal › Article
- 2010
-
Mark
Foxa2 and Nurr1 Synergistically Yield A9 Nigral Dopamine Neurons Exhibiting Improved Differentiation, Function, and Cell Survival
(
- Contribution to journal › Article